Visits: 44116, Avg visit time (secs): 108,57 Back to Index
| Page | Hits | Percent |
|---|---|---|
| /home.html | 14115 | 32,00% |
| 13210 | 29,94% | |
| /programmes.html | 6349 | 14,39% |
| /executive.html | 1709 | 3,87% |
| /gsk/efsd-gsk-rfa08.html | 756 | 1,71% |
| /partners.html | 689 | 1,56% |
| /recipients.html | 586 | 1,33% |
| /msd/albert-renold/efsd-msd-arenold.html | 458 | 1,04% |
| /reviewers.html | 406 | 0,92% |
| /reports.html | 337 | 0,76% |
| /novo-t2/efsd-novo-t2-rfa08.html | 322 | 0,73% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 12461 | 28,25% |
| /programmes.html | 6349 | 14,39% |
| /regulations.html | 1800 | 4,08% |
| /msd/albert-renold/efsd-msd-arenold.html | 1343 | 3,04% |
| /partners.html | 1277 | 2,89% |
| /home.html | 1174 | 2,66% |
| /lilly/programme/efsd-lilly-rfa10.html | 1065 | 2,41% |
| /recipients.html | 1060 | 2,40% |
| /lilly/programme/efsd-lilly-rfa09.html | 788 | 1,79% |
| /lilly/programme/efsd-lilly-rfa08.html | 738 | 1,67% |
| /novo_2010/novo_2010_ rfa.html | 602 | 1,36% |